Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC02960 (Long intergenic non-protein coding RNA 2960) is annotated as a human lincRNA gene, transcribing a non-coding RNA molecule longer than 200 nucleotides that does not overlap with protein-coding genes. LincRNAs generally modulate the expression of neighboring genes and may participate in tissue-specific regulatory functions. The molecular and disease roles of LINC02960 specifically have not been characterized, and, like many lincRNAs, its function remains to be fully defined. There is currently no evidence of this molecule serving as a receptor, enzyme, transporter, or other classical drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2960 (LINC02960).